🇺🇸 FDA
Patent

US 9102660

Process of making prostacyclin compounds with linker thiol and pegylated forms

granted A61PA61P9/12

Quick answer

US patent 9102660 (Process of making prostacyclin compounds with linker thiol and pegylated forms) held by United Therapeutics Corporation expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P9/12